Marinus Pharmaceuticals Inc (NASDAQ: MRNS) closed at $ 11.64 on Friday after losing $ 0.11 (0.94%) on volume of 92,672 shares. The stock ranged from a high of $ 11.89 to a low of $ 11.45 while Marinus’ market cap now stands at $ 427,560,887.
About Marinus Pharmaceuticals Inc
Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapies to treat rare seizure disorders. Ganaxolone is a positive allosteric modulator of GABAA receptors that acts on a well-characterized target in the brain known to have anti-epileptic, anti-depressant and anti-anxiety potential. Ganaxolone is under development as intravenous and oral doses intended to maximize the therapeutic reach of adult and pediatric patient populations in acute and chronic care settings. Marinus recently completed the first-ever pivotal phase 3 trial in children with CDKL5 deficiency disorder and is conducting a phase 3 refractory status epilepticus trial, a phase 2 trial in tuberous sclerosis Bourneville and a phase 2 proof of concept trial on PCDH19. -related to epilepsy.
Visit the Marinus Pharmaceuticals Inc profile for more information.
The daily solution
Pfizer Inc (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced Thursday that they have asked the United States Food and Drug Administration (FDA) to extend emergency use authorization for their COVID-vaccine. 19 to cover children aged five to 11.
Nissan Motor Co Ltd (OTC: NSANY) will suspend production at two Mexican factories for several days this month due to the continued shortage of semiconductor chips.
Home Depot Inc (NYSE: HD) partners with Walmart Inc (NYSE: WMT) to provide same-day and next-day deliveries of tools, paint, and other online shopping to customer doors.
About the Nasdaq Stock Market
The Nasdaq Stock Market is a global leader in trading data and services, as well as the listing of stocks and options. The Nasdaq is the world’s largest stock exchange for options volume and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.
To get more information about Marinus Pharmaceuticals Inc and keep up with the latest company updates, you can visit the company profile page here: Marinus Pharmaceuticals Inc. Profile For more financial market information, no. be sure to visit Equities News. Also, don’t forget to sign up for the Daily Fix to get the best stories delivered to your inbox 5 days a week.
Sources: The chart is provided by TradingView based on 15 minute lag prices. All other data is provided by IEX Cloud as of 8:05 p.m. ET on the day of publication.
The views and opinions expressed in this article are those of the authors and do not represent the views of equities.com. Readers should not take the author’s statements as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please visit: http://www.equities.com/disclaimer
United Airlines expands December schedule to 3,500 daily domestic flights
Moody’s sees long-term economic benefit from fuller racial integration
IBM makes COVID-19 vaccine mandatory for all U.S. employees by December 8
Pfizer-BioNTech Calls on FDA to Clear COVID-19 Vaccine for Children 5-11 Years of Age
Home Depot signs up for Walmart’s GoLocal delivery service
Nissan institutes work stoppages in Mexico for part of October
‘Pandora Papers’ Leak Reveals How World Leaders and Billionaires Protect Assets of Tax Collectors
New factory orders rise 1.2% in August, more than expected